This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

From Little Akorn Grows a Great Stock

NEW YORK (TheStreet) -- This is the year of the small and mid-cap domestic stock, such as Akorn (AKRX - Get Report). For many smart investors, it is the year that traditional asset allocation among stocks, bonds and gold has finally outlived it usefulness.

Data from Best Stocks Now App

I am not a believer in the traditional asset allocation models that are built on the Model Portfolio Theory that says investors need so much money in stocks -- often for growth -- and so much in bonds - often for income. And often so much in gold for security.

There are lots of places to get income besides bonds. Instead, I move around among the various asset classes as world and economic conditions dictate.

When it became obvious about 18 months ago that interest rates had nowhere to go but up, and the Federal Reserve had no other choice but to tighten at some point, I got out of the way of the freight train that was headed right for the market.

I got out of bonds, just in time to avoid the beating that bonds took this year: The U.S. long bond, as seen by the iShares Barclays 20+ Yr Treasury Bond (TLT) exchange-traded fund, is now down 14.7% for the year to date.

I have also not had any exposure to the emerging markets as they have been at the bottom of my asset class rankings since the beginning of the year. That too has helped my performance greatly in 2013 as the emerging markets as a whole are down about 9% year-to-date. Contrast this with the 24% return of the U.S. S&P 500 index.

Gold has also been a bad place to be in 2013 as it is now down over 23% year-to-date. So much for asset allocation into gold.

Instead, I have been heavily focused in small and mid-cap domestic stocks which have led the market all year long. The S&P 500 small-cap index is up a whopping 32.8% year to date.

Being in the right sectors of the market is a great place to start selecting investments. 2013 has been a year that has greatly favored pharmaceutical, biotech, and technology stocks. Of course, this is where a lot of small and mid-cap stocks reside.

1 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG
AKRX $48.48 0.00%
AAPL $123.25 0.00%
FB $83.30 0.00%
GOOG $548.34 0.00%
TSLA $185.00 0.00%

Markets

DOW 17,712.66 +34.43 0.19%
S&P 500 2,061.02 +4.87 0.24%
NASDAQ 4,891.2190 +27.8570 0.57%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs